DW-330SR2

· Daewon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DW-330SR2, covering 2016-10-10 to 2016-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients [Phase 3]